Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Net income changed +739.1% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash-flow margin changed +1039 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Short-term borrowings changed -100.0% from the comparable as-filed period.
Revenue changed +5.0% from the comparable as-filed period.
Cash & equivalents changed +14.4% from the comparable as-filed period.
Gross margin changed -11 basis points from the comparable as-filed period.
Receivables / revenue changed -277 basis points from the comparable as-filed period.
Total assets changed -7.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Current long-term debt changed +12.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Shares outstanding changed +0.6% from the comparable as-filed period. The change ranks at the 38th percentile of 8 prior comparable changes.
Gross profit changed +4.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory changed -6.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
SBC / revenue changed -23 basis points from the comparable as-filed period.
Cost of revenue changed +5.1% from the comparable as-filed period.
Stock-based compensation changed -14.3% from the comparable as-filed period.
Research & development changed +5.9% from the comparable as-filed period.
Working capital changed -4.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Current liabilities changed +0.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Trade receivables changed +0.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Current assets changed -1.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Working capital / assets changed +55 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Current ratio changed -2.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Selling, general & administrative changed +3.1% from the comparable as-filed period.
R&D / revenue changed +4 basis points from the comparable as-filed period.
Operating income changed +13.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating margin changed +53 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Short-term borrowings changed -100.0% from the comparable as-filed period.
Revenue changed +5.3% from the comparable as-filed period.
Gross margin changed -40 basis points from the comparable as-filed period.
Current ratio changed -15.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating cash-flow margin changed +191 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Working capital changed -10.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Current assets changed +3.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Total assets changed -6.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Inventory changed -5.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 3 consecutive comparable moves in the opposite direction.
Shares outstanding changed +0.7% from the comparable as-filed period. The change ranks at the 50th percentile of 8 prior comparable changes.
Gross profit changed +4.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Cost of revenue changed +6.0% from the comparable as-filed period.
SBC / revenue changed -13 basis points from the comparable as-filed period.
Trade receivables changed +4.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Research & development changed -3.7% from the comparable as-filed period.
Working capital / assets changed -93 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
R&D / revenue changed -41 basis points from the comparable as-filed period.
Stock-based compensation changed -5.7% from the comparable as-filed period.
Operating cash flow / net income changed -5.1% from the comparable as-filed period.
Receivables / revenue changed -39 basis points from the comparable as-filed period.
Selling, general & administrative changed +2.4% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.